|
40
|
4181A
|
AVASTIN 25MG/ML INJ (ROC/AHI) BEVACIZUMAB
|
100MG VIAL
|
C
|
1,003.06
|
25MG/ML
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
41
|
4181A
|
AVASTIN 25MG/ML INJ (ROC) BEVACIZUMAB (C)
|
100MG VIAL
|
C
|
1003.0616
|
25MG/ML
|
0
|
2024-04-01
|
2026-03-31
|
|
|
|
0
|
|
40
|
4181B
|
AVASTIN 25MG/ML INJ (ROC/AHI) BEVACIZUMAB
|
400MG VIAL
|
C
|
4,012.25
|
25MG/ML
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
41
|
4181B
|
AVASTIN 25MG/ML INJ (ROC) BEVACIZUMAB (C)
|
400MG VIAL
|
C
|
4012.2462
|
25MG/ML
|
0
|
2024-04-01
|
2026-03-31
|
|
|
|
0
|
|
40
|
4181BH
|
BEMABIX 25MG/ML INJ (ABB/PHA) BEVACIZUMAB
|
4ML VIAL
|
C
|
856.27
|
25MG/ML
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
40
|
4181BH
|
BEMABIX 25MG/ML INJ (ABB/PHA) BEVACIZUMAB (C)
|
4ML VIAL
|
C
|
856.27
|
25MG/ML
|
|
2022-04-01
|
2023-04-18
|
No
|
No
|
Delete from contract
|
0
|
|
40
|
4181BJ
|
BEMABIX 25MG/ML INJ (ABB/PHA) BEVACIZUMAB
|
16ML VIAL
|
C
|
3,811.28
|
25MG/ML
|
0
|
2022-04-01
|
2024-03-31
|
|
|
|
0
|
|
40
|
4181BJ
|
BEMABIX 25MG/ML INJ (ABB/PHA) BEVACIZUMAB (C)
|
16ML VIAL
|
C
|
3811.28
|
25MG/ML
|
|
2022-04-01
|
2023-03-31
|
No
|
No
|
Delete from contract
|
0
|
|
41
|
4181BR
|
BEVACIREL 25MG/ML INJ (RLS) BEVACIZUMAB (C)
|
4ML VIAL
|
C
|
430.5825
|
25MG/ML
|
0
|
2024-04-01
|
2026-03-31
|
|
|
|
0
|
|
41
|
4181BS
|
BEVIXA 25MG/ML INJ (INC) BEVACIZUMAB (C)
|
4ML VIAL
|
C
|
925.7524
|
25MG/ML
|
0
|
2024-04-01
|
2026-03-31
|
|
|
|
0
|